Double maintains 1 strategies that include EWTX - Edgewise Therapeutics, Inc.
Current Value
$14.481 Year Return
Current Value
$14.481 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -29.09% | $140.49M | 0.59% |
VIXY | -24.11% | $109.64M | 0.85% |
BTAL | -23.52% | $361.41M | 1.43% |
FXY | -13.50% | $838.61M | 0.4% |
BWX | -11.54% | $1.41B | 0.35% |
SPTS | -10.37% | $5.76B | 0.03% |
GOVZ | -9.67% | $249.31M | 0.1% |
STXT | -9.14% | $134.15M | 0.49% |
IVOL | -9.13% | $353.94M | 1.02% |
AGZ | -8.57% | $607.46M | 0.2% |
XONE | -8.52% | $603.24M | 0.03% |
SCHP | -8.38% | $12.81B | 0.03% |
IBTH | -8.24% | $1.53B | 0.07% |
IBTI | -8.02% | $995.39M | 0.07% |
GCOR | -7.91% | $537.55M | 0.08% |
IEI | -7.30% | $16.09B | 0.15% |
BILS | -7.01% | $3.96B | 0.1356% |
IBTL | -7.01% | $367.56M | 0.07% |
LGOV | -6.94% | $684.47M | 0.67% |
IBTM | -6.92% | $313.33M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SCMB | -0.01% | $1.94B | 0.03% |
MLN | 0.03% | $532.71M | 0.24% |
MBB | -0.03% | $37.74B | 0.04% |
MMIT | -0.05% | $829.60M | 0.3% |
USDU | -0.06% | $173.44M | 0.5% |
BILZ | 0.06% | $876.85M | 0.14% |
TBIL | -0.07% | $5.76B | 0.15% |
ISTB | -0.07% | $4.45B | 0.06% |
JMBS | -0.21% | $5.40B | 0.22% |
FXE | 0.21% | $525.40M | 0.4% |
WEAT | 0.22% | $115.83M | 0.28% |
FLCB | -0.22% | $2.52B | 0.15% |
FIXD | -0.22% | $3.54B | 0.65% |
ITM | 0.24% | $1.97B | 0.18% |
UUP | 0.28% | $292.27M | 0.77% |
MTBA | 0.33% | $1.56B | 0.17% |
VRIG | 0.36% | $1.19B | 0.3% |
GTO | 0.38% | $1.89B | 0.35% |
TLTW | -0.39% | $1.03B | 0.35% |
JCPB | -0.39% | $6.25B | 0.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XPH | 39.84% | $136.58M | 0.35% |
XBI | 37.62% | $4.85B | 0.35% |
IBB | 35.99% | $5.22B | 0.45% |
EALT | 35.07% | $134.81M | 0.69% |
KRMA | 35.02% | $603.78M | 0.43% |
IWO | 35.02% | $11.36B | 0.24% |
IWC | 34.91% | $766.88M | 0.6% |
KJAN | 34.89% | $305.13M | 0.79% |
CGBL | 34.77% | $2.14B | 0.33% |
IBHH | 34.73% | $223.00M | 0.35% |
GDIV | 34.60% | $225.25M | 0.5% |
BALT | 34.58% | $1.44B | 0.69% |
XDTE | 34.48% | $382.21M | 0.95% |
SECT | 34.48% | $1.98B | 0.78% |
SPMO | 34.33% | $7.35B | 0.13% |
FLQL | 34.26% | $1.44B | 0.29% |
SIXG | 34.12% | $567.70M | 0.3% |
ACIO | 34.09% | $1.84B | 0.79% |
SNSR | 34.00% | $223.26M | 0.68% |
XSMO | 33.95% | $1.51B | 0.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PGNY | -27.16% | $1.88B | -20.33% | 0.00% |
LTM | -13.14% | $11.01B | -96.75% | 2.75% |
KSPI | -12.94% | $15.59B | -31.07% | 2.14% |
ED | -9.96% | $36.75B | +5.26% | 3.28% |
AIFU | -9.84% | $9.85M | -95.03% | 0.00% |
CBOE | -9.54% | $22.95B | +20.67% | 1.12% |
LITB | -9.28% | $21.28M | -72.45% | 0.00% |
AMT | -7.56% | $99.10B | +8.59% | 3.09% |
VHC | -7.53% | $34.69M | +74.89% | 0.00% |
MUSA | -7.49% | $8.91B | +2.63% | 0.53% |
SPWH | -7.22% | $74.28M | -43.44% | 0.00% |
FATBB | -6.73% | $50.77M | -11.65% | 9.83% |
TTEC | -6.46% | $250.65M | -31.86% | 0.00% |
COR | -6.35% | $55.43B | +28.90% | 0.56% |
AEP | -6.09% | $54.28B | +9.80% | 3.61% |
AQB | -5.92% | $2.96M | -61.58% | 0.00% |
CL | -5.90% | $72.64B | -5.18% | 2.25% |
FTS | -5.56% | $23.72B | +15.88% | 3.70% |
KO | -5.49% | $308.23B | +13.09% | 2.75% |
HE | -5.48% | $1.83B | -10.25% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BELFB | 40.51% | $960.65M | +17.20% | 0.36% |
KYMR | 38.79% | $1.95B | -15.67% | 0.00% |
AER | 38.32% | $20.06B | +25.28% | 1.14% |
RVMD | 38.06% | $7.35B | +1.15% | 0.00% |
XHR | 37.45% | $1.21B | -17.52% | 4.07% |
KN | 36.29% | $1.48B | -2.96% | 0.00% |
KEYS | 36.17% | $28.48B | +5.10% | 0.00% |
PK | 35.89% | $2.16B | -32.12% | 9.23% |
CAT | 34.60% | $164.52B | -0.26% | 1.61% |
ATXS | 34.36% | $225.17M | -57.69% | 0.00% |
ITT | 34.30% | $11.82B | +8.44% | 0.87% |
IMVT | 34.06% | $2.36B | -55.78% | 0.00% |
WEAV | 34.01% | $813.47M | +18.51% | 0.00% |
CRNX | 33.92% | $2.92B | -39.88% | 0.00% |
RNST | 33.71% | $3.38B | +14.53% | 2.47% |
DRI | 33.44% | $24.46B | +38.03% | 2.68% |
NOVT | 33.32% | $4.66B | -21.25% | 0.00% |
IPGP | 33.08% | $2.78B | -26.19% | 0.00% |
NCNO | 32.96% | $2.82B | -23.19% | 0.00% |
WAB | 32.86% | $34.95B | +22.55% | 0.42% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GIS | -0.01% | $29.79B | -23.81% | 4.42% |
CNK | 0.01% | $3.67B | +78.94% | 0.25% |
PINC | -0.03% | $1.88B | +15.22% | 3.69% |
CAG | -0.10% | $10.87B | -26.52% | 6.17% |
CCRN | 0.19% | $457.33M | -5.30% | 0.00% |
NEUE | -0.23% | $62.05M | +13.56% | 0.00% |
TIMB | -0.30% | $8.38B | +3.30% | 2.99% |
REYN | 0.33% | $4.88B | -20.08% | 4.00% |
SVV | 0.34% | $1.52B | -27.81% | 0.00% |
SRRK | 0.35% | $2.92B | +115.29% | 0.00% |
WBA | -0.38% | $9.67B | -39.04% | 6.69% |
CLX | -0.39% | $16.64B | -1.45% | 3.61% |
GO | -0.41% | $1.37B | -35.98% | 0.00% |
HRL | 0.42% | $16.59B | -16.43% | 3.81% |
XEL | 0.42% | $41.10B | +27.59% | 3.10% |
MED | 0.48% | $146.95M | -47.28% | 0.00% |
AWK | -0.51% | $27.37B | +4.54% | 2.22% |
ADC | -0.51% | $8.13B | +22.47% | 4.08% |
NOVA | 0.58% | $27.46M | -95.24% | 0.00% |
FE | -0.60% | $24.49B | +5.52% | 4.06% |
Yahoo
Activists also report to the SEC on Edgewise Therapeutics, SLM, Insight Enterprises, and Dun & Bradstreet Holdings.
Yahoo
The mean of analysts' price targets for Edgewise Therapeutics (EWTX) points to a 174.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Yahoo
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, at 9:00 am ET.
Yahoo
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2025 and recent business highlights.
Finnhub
Edgewise Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 40.8 million compared to USD 28.53...
Yahoo
We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other top small cap stocks to buy with biggest upside potential. On April 24, Jill Carey Hall, BofA Securities head […]